It's no secret that the American health care system is complicated, and getting prescription medications can be particularly bewildering and costly. One option for consumers is ...

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...

The GoodRx for Weight Loss telemedicine subscription is available for an introductory rate of $39 per month through January ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make ...

Wondering if you'll save money getting your vaccines and immunization shots at Costco? Here's what to know about the Costco ...

A Michigan doctor has filed a lawsuit against GoodRx, alleging that the company is orchestrating an illegal price-fixing scheme with major pharmacy benefit managers that artificially suppresses ...

Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...

As the U.S. stock market continues its upward trajectory, with major indexes marking their biggest weekly rise since June, investors are increasingly exploring diverse opportunities to capitalize on ...

The consensus analyst price target for GoodRx Holdings has been revised downward, moving from $5.37 to $5.09 per share. This modest reduction reflects shifting perspectives among analysts regarding ...

Novo Nordisk announced that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients.

BofA lowered the firm’s price target on GoodRx (GDRX) to $3 from $3.40 and keeps an Underperform rating on the shares after the company announced ...

The Danish company is trying to regain market share from Eli Lilly — which makes Mounjaro and Zepbound — by making its weight ...